Updated Jul 16, 2026
Camblong Jurgi has filed 9 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.62M.

Jurgi Camblong is the Chief Executive Officer of SOPHiA GENETICS SA, a company specializing in data-driven medicine and genomic analysis. He has been instrumental in leading the company towards advancements in the field of healthcare technology, focusing on the integration of artificial intelligence and big data in genomic medicine.
| Role | Executive Chairman, Director |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-14 | SOPH | SOPHiA GENETICS SA | S — Open-market sale [10b5-1] | 8.5K | $5.62 | $48K |
| 2026-07-08 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 17.7K | $5.28 | $93K |
| 2026-07-07 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 22.5K | $5.25 | $118K |
| 2026-07-01 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 200 | $6.30 | $1K |
| 2026-07-01 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 19.6K | $6.02 | $118K |
| 2026-07-01 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 45.4K | $6.14 | $279K |
| 2026-07-01 | SOPH | SOPHiA GENETICS SA | M — Option exercise | 45.4K | $3.16 | $144K |
| 2026-07-01 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 350 | $6.00 | $2K |
| 2026-07-01 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 18.1K | $5.87 | $106K |
| 2026-07-01 | SOPH | SOPHiA GENETICS SA | M — Option exercise | 18.1K | $3.16 | $57K |
| 2026-06-29 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 31.9K | $5.84 | $186K |
| 2026-06-29 | SOPH | SOPHiA GENETICS SA | M — Option exercise | 31.9K | $3.16 | $101K |
| 2026-06-29 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 18.1K | $5.73 | $104K |
| 2026-06-29 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 1.4K | $5.70 | $8K |
| 2026-06-11 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 8.5K | $5.24 | $45K |
| 2026-05-20 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 4.5K | $4.60 | $21K |
| 2026-05-12 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 8.5K | $5.09 | $43K |
| 2026-04-21 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 4.5K | $5.21 | $23K |
| 2026-04-16 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 17.5K | $5.00 | $87K |
| 2026-04-16 | SOPH | SOPHiA GENETICS SA | S — Open-market sale | 43.1K | $4.96 | $214K |
Jurgi Camblong is the Chief Executive Officer of SOPHiA GENETICS SA, a company specializing in data-driven medicine and genomic analysis. He has been instrumental in leading the company towards advancements in the field of healthcare technology, focusing on the integration of artificial intelligence and big data in genomic medicine.…
9 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 23 open-market sales ($1.62M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Camblong Jurgi profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.